Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-09-24

Clinical Trial Update: Efficacy, Safety, and Tolerability of HTS-519 Insert in Patients With Toenail Fungus of the Big Toenail [Phase 2]

View source ↗

Summary

Phase 2 trial update on HTS-519 Insert for onychomycosis (toenail fungus) assessing efficacy, safety, and tolerability.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HTS-519 Insert

Snippet

Sponsor: Hallux, Inc. | Conditions: Onychomycosis | Phase 2 | Status: COMPLETED | Results posted: 2019-09-24